Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 1997
Publications 1997

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Atalay M et al. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress.
2 Balkau B et al. Non-cardiovascular disease mortality and diabetes mellitus.
3 Chambless L et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990.
4 Eriksson J et al. Akarboosi diabeteksen hoidossa.
5 EUROASPIRE Study Group. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results.
6 Farrer LA et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.
7 Ferrannini E et al. Insulin action and non-esterified fatty acids.
8 Ferrannini E et al. Insulin resistance and hypersecretion in obesity.
9 Ferrannini E et al. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity.
10 Haffner SM et al. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
11 Haffner SM et al. Insulin sensitivity and acute insulin response in African American, non-Hispanic-white and hispanic subjects with NIDDM: the insulin resistance atherosclerosis study.
12 Haffner SM, Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease.
13 Haffner SM et al. Leptin concentrations, sex hormones and cortisol in non-diabetic men.
14 Haffner SM et al. Leptin concentrations and insulin sensitivity in normoglycemic men.
15 Haffner SM et al. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men.
16 Haffner SM et al. The Homeostasis model in the San Antonio heart study.
17 Haffner SM et al. Are risk factors for conversion to NIDDM similar in high and low risk populations?
18 Haffner SM et al. Leptin concentrations in women in the San Antonio Heart Study: Effect of menopausal status and postmenopausal hormone replacement therapy.
19 Hansson L et al. The Captopril Prevention Project (CAPPP) in hypertension - baseline data and current status.
20 Hartikainen J et al. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction.
21 Hartikainen JEK et al. Sympathetic predominance of cardiac autonomic regulation in patients with left free wall accessory pathway and orthodromic atrioventricular reentrant tachycardia.
22 Heikkinen A-M et al. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: A prospective, controlled, randomized stydy.
23 Heikkinen A-M et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
24 Heikkinen M et al. Usefulness of anti-helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
25 Heikkinen MT et al. Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy.
26 Heino A et al. Systemic and regional effects of experimental gradual splanchnic ischemia.
27 Helkala E-L et al. Stability of age-associated memory impairment during a longitudinal population-based study.
28 Janatuinen E et al. Kaura ja keliakia.
29 Jantunen E et al. Alkuvaiheen kokemuksia veren kantasolujen siirroista KYS:ssa.
30 Jantunen E et al. Incidence and risk factors for invasive fungal infektions in allogeneic BMT recipients.
31 Julkunen R. Oats and coeliac disease.
32 Juvonen J et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves.
33 Karhunen L et al. Serum leptin and short-term regulation of eating in obese women.
34 Kautzner J et al. Effects of upright posture on filtered QRS parameter of the signal-averaged electrocardiogram in healty volunteers.
35 Kautzner J et al. The effects of reflex parasympathetic stimulation on the QT interval and QT dispersion.
36 Kettunen R. Sydänperäiset kivut.
37 Kiviniemi M et al. Kehittyvä tahdistinhoito.
38 Kjekshus J et al. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
39 Kuusisto J. Aorttaläppästenoosin patogeneesi selviämässä.
40 Kuusisto J et al. Association between features of the insulin resistance syndrome and Alzheimer`s disease independently of apolipoprotein E4 phenotype:cross sectional population based study.
41 Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus: lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus.
42 Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes.
43 Laitinen M et al. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.
44 Lehto S et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.
45 Malkki M et al. The human hexokinase II gene promoter: functional characterization and detection of variants among patients with NIDDM.
46 Miettinen H, Salomaa V. Diabetes and macrovascular disease.
47 Miettinen TA et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris with myocardial infarction or angina pectoris: Findings from the Scandinavian Survival Study (4S).
48 Momiyama Y et al. Exercise-induced t-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.
49 Mustonen J et al. Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease.
50 Mykkänen L et al. The relation of proinsulin, insulin and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects.
51 Mykkänen L et al. Relationship of LDL size to insulin sensitivity in normoglycemic men.
52 Mykkänen L et al. Low insulin sensitivity is associated with clustering of cardiocascular risk factors.
53 Mykkänen L et al. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS).
54 Mähönen M et al. The validity of hospital discharge data on coronary heart disease in Finland.
55 Niskanen L et al. Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects.
56 Niskanen L et al. Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.
57 Niskanen LK et al. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss.
58 Oliver MF et al. Management of hyperlipidaemia: Why, when and how to treat.
59 Pihlajamäki J et al. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
60 Pyörälä K et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
61 Rissanen J et al. The trp64arg polymorphism of the beta3-adrenergic receptor gene.
62 Rissanen J et al. The ala54thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects.
63 Rissanen J et al. New variants in the glycogen synthase gene (GIn71His, Met416Val) in patients with NIDDM from eastern Finland.
64 Salomaa VV et al. Fatalities from myocardial infarction in Nordic Countries and Lithuania.
65 Sans S et al. The burden of cardiovascular diseases mortality in Europe: Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity Statistics in Europe.
66 Schwab US et al. Metabolic effects of diets rich in saturated and omega-6 polyunsatured fatty acids in healthy young females.
67 Schwab US et al. Palmitic and stearic acid enriched diets have similar effects on glucose metabolism in healthy young females.
68 Sipiläinen R et al. Polymorphism of the Beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns.
69 Sipiläinen R et al. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects.
70 Strandberg TE et al. Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.
71 Suomen Gastroenterologiayhdistys Ry. Keliakian hoitosuositus.
72 The International Steering Committee on behalf of the MERIT-HF Study Group, Halinen M. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in heart failure (MERIT-HF).
73 The Task Force of the European Society of Cardiology. Management of stable angina pectoris: Recommendations of the Task Force ot the European Society of Cardiology.
74 Thrombin Inhibition in Myocardial Ischaemia (TRIM) study group. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients: A double-blind, randomized, dose-finding study.
75 Torpström A et al. Tymektomian merkitys myasthenia graviksen hoidossa.
76 Turpeinen AK et al. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin responce.
77 Töyry JP et al. Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction? Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects.
78 Töyry JP et al. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM.
79 Uusitupa M et al. Ravinto,terveytemme perusta nyt ja tulevaisuudessa.
80 Vanhanen M et al. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.
81 Vauhkonen I et al. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.
82 Vidgren HM et al. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects.
83 Viinamäki H et al. Laman vaikutus suomalaisten mielenterveyteen.
84 Viinamäki H et al. Factors predicting health behaviour.
85 Viinamäki H et al. Evolution of postpartum mental health.
86 WHO MONICA Project et al. Mild myocardial infarction - a classification problem in epidemiologic studies.
87 Yki-Järvinen H et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008